However, we hypothesize that there will be a differential representation, to some degree, in the molecular mechanisms and/or metabolic regulation involved in FKRP-related dystroglycanopathies, and as a result, these types of disorders should be thoroughly evaluated as well. Here, FKRP is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.